Superbugs: The silent pandemic that could make COVID-19 look like a trial run

  • news

  • Health

Superbugs: The silent pandemic that could make COVID-19 look like a trial run

Superbugs driven by antimicrobial resistance (AMR) are a global health threat. Dr. Kasaragod urges coordinated action, strict regulations, public awareness and research to prevent a devastating health care crisis.

Image – Canva

superbugMicroorganisms resistant to antimicrobial drugs, pose A Serious threat to global healthAccording to Dr. Arvind Balakrishna Kasargod, director of medical services, Cloudnine Group of Hospitals, these drug-resistant pathogens emerge due to antimicrobial resistance (AMR), a phenomenon driven by the misuse and overuse of antimicrobial drugs. Infections caused by superbugs lack effective treatments, potentially leading to an even worse crisis Covid-19 pandemic,
impact of amr
Dr Kasaragod says AMR weakens essential medicines, complicating treatment of common infections and increasing mortality. More than 1.2 million people lose their lives every year drug resistant infection Worldwide, estimates suggest this figure could rise to 10 million by 2050 if no action is taken. Resistant pathogens cross borders, jeopardizing progress modern medicine And putting enormous strain on health care systems.
“Without effective antimicrobial drugs, routine surgeries and medical procedures become high-risk endeavors,” explains Dr. Kasaragod. He further said that there is an urgent need for coordinated global action.
Root causes of superbugs
India, the largest consumer of antibiotics in the world, exemplifies the factors promoting AMR. Dr. Kasaragod identifies over-prescription, self-medication and unregulated access to antibiotics as significant contributors. According to The Lancet, between 2000 and 2015, antibiotic use in India increased by 103%.
Agricultural practices also play a role, with antibiotics routinely used in livestock. “Resistant bacteria can transfer to humans through the food chain and environmental exposure, further exacerbating the crisis,” says Dr. Kasaragod.
Challenges in tackling AMR
Efforts to curb AMR face many obstacles, including lack of awareness, economic interests, and inadequate research funding. “AMR is a complex issue that requires systemic change in health care, agriculture and public policy,” says Dr. Kasaragod.
Global cooperation is important, because resistant germs spread easily through human activity, food, and the environment. However, implementation of regulations and public education campaigns often fail due to financial and logistical challenges.
call to action
Dr. Kasaragod urges immediate, coordinated efforts to tackle AMR.
healthcare professionals: Adhere to antimicrobial stewardship programs and educate patients about the risks of misuse.
policy makers: Enact strict regulations on antibiotic sales and agricultural use.
Public awareness: Increase campaigns highlighting the dangers of AMR and self-medication.
research investment:Funding the development of new antibiotics, rapid diagnostics and alternative treatments.
international cooperation: Promote integrated strategies and data sharing to counter the global spread of resistance.
“The time to act is now,” emphasizes Dr. Kasaragod. “If we fail, future generations will face a world where minor infections will become life-threatening, routine surgeries will become very dangerous, and medical advances will be reversed.”
Get the latest news live on Times Now with breaking news and top headlines from around the world.
Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Exit mobile version